Chemical activators of PRB3 can modulate its activity through various biochemical pathways, primarily through the modulation of intracellular signaling molecules such as calcium and cyclic nucleotides. Calcium ionophores like A23187 and Ionomycin raise intracellular calcium levels, which in turn can activate calcium-dependent kinases that phosphorylate PRB3, resulting in its activation. Similarly, Thapsigargin increases cytosolic calcium by inhibiting the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), thus indirectly promoting the activation of PRB3 through calcium-mediated signaling pathways. Phorbol 12-myristate 13-acetate (PMA) and 1,2-Dioctanoyl-sn-glycerol (DiC8) directly activate protein kinase C (PKC), a kinase that can phosphorylate PRB3. PKC serves as a nodal point in the signaling cascade, and its activation by these chemicals ensures the phosphorylation and consequent activation of PRB3.
On the other side of the signaling spectrum, Forskolin and Dibutyryl-cAMP (db-cAMP) increase intracellular cAMP levels, which activate protein kinase A (PKA). PKA is another kinase known to phosphorylate PRB3, leading to its activation. Zaprinast works through a similar mechanism by elevating cGMP levels, thereby activating cGMP-dependent protein kinases that can also phosphorylate PRB3. Additionally, chemicals like Okadaic Acid and Calyculin A inhibit protein phosphatases, resulting in sustained phosphorylation and continued activation of PRB3 due to a lack of dephosphorylation. Anisomycin activates stress-activated protein kinases, which then go on to phosphorylate PRB3. Even though H-89 is an inhibitor of PKA, it can lead to the compensatory activation of other kinases capable of phosphorylating and activating PRB3, showcasing the complexity and interconnectivity of cellular signaling mechanisms. Each of these chemicals, through their distinct mechanisms of action, ensures the activation of PRB3 by phosphorylation, highlighting the multi-faceted nature of cellular regulatory systems.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $54.00 $128.00 $199.00 $311.00 | 23 | |
A23187 functions by increasing intracellular calcium levels, which can lead to the activation of calcium-dependent protein kinases known to phosphorylate PRB3, thereby directly leading to the activation of PRB3. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $76.00 $265.00 | 80 | |
Ionomycin acts similarly to A23187 by raising intracellular calcium concentrations, which can activate calcium/calmodulin-dependent protein kinases that phosphorylate and activate PRB3. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
PMA activates protein kinase C (PKC), and PKC can phosphorylate PRB3 as part of its downstream effects, directly leading to the activation of PRB3. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin raises intracellular cAMP levels, which activates protein kinase A (PKA). PKA can then phosphorylate PRB3, leading to its activation. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
Thapsigargin inhibits the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), leading to increased cytosolic calcium levels, which can activate kinases that phosphorylate and activate PRB3. | ||||||
1,2-Dioctanoyl-sn-glycerol | 60514-48-9 | sc-202397 sc-202397A | 10 mg 50 mg | $46.00 $249.00 | 2 | |
DiC8 serves as a direct activator of PKC due to its diacylglycerol-like activity. Activated PKC can phosphorylate PRB3, resulting in its activation. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $285.00 $520.00 $1300.00 | 78 | |
Okadaic Acid inhibits protein phosphatases, leading to sustained phosphorylation of proteins, including PRB3. This inhibition can result in the continued activation of PRB3 due to lack of dephosphorylation. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $97.00 $254.00 | 36 | |
Anisomycin activates stress-activated protein kinases, which can phosphorylate and activate PRB3 as a downstream effect. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $103.00 $245.00 | 8 | |
Zaprinast increases cGMP levels, which can activate cGMP-dependent protein kinases. These kinases can phosphorylate PRB3, leading to its activation. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $45.00 $130.00 $480.00 $4450.00 | 74 | |
db-cAMP is a cAMP analog that can diffuse into cells and increase intracellular cAMP levels, thereby activating PKA, which in turn can phosphorylate and activate PRB3. | ||||||